Stephenson Harwood

Corporate

Michelle is a partner in the corporate team, specialising in private M&A, joint ventures and equity fundraising (from Series A onwards) within a broad range of sectors, with specific focus on the life sciences, technology and green tech industries.

Michelle has a particular interest in the life sciences industry, having spent time on secondment to FTSE 250 company BTG plc (since acquired by Boston Scientific), and Astellas Pharma.

Michelle has a broad practice, acting for purchasers and sellers on M&A transactions and both company-side and investor-side on equity investments (ranging from Series A onwards), as well as a wider corporate practice spanning joint venture, corporate reorganisations and general advisory support.

Michelle's recent experience includes acting for: Industrial Physics on its acquisition of Manufacturing; e-therapeutics plc on its £12.4million equity fundraise; a life sciences company on its divestment of a legacy product; a seller on their sale of their stake in a London REIT for £436 million; AIM listed Focusrite plc on its acquisition of Linea Research Holdings; Anglia Maltings on their entry into a three way joint venture with Frontier Agriculture and Camgrain; Highview Power on their growth capital round which totalled $70 million; the sellers of Arcola Energy on their sale to Canadian listed company Ballard Power Systems; CLS Group on the sale of Future Climate Info to Canadian listed Dye & Durham; 3 Step IT on its strategic partnership with BNP Paribas Leasing Solutions to create a leading integrated IT leasing business across various European jurisdictions; and various early stage companies and VC funds on equity funding rounds (from Series A onwards).